Boiron SA is a leading pharmaceutical company specializing in the production and distribution of homeopathic medicines, recognized as the world's largest manufacturer in this field. Founded in 1932 by twin brothers Jean and Henri Boiron, pharmacists with expertise in science and microbiology, it originated as the Central Homeopathic Laboratory of France in Paris and was formally incorporated as Laboratoires Boiron in 1967. Headquartered in Ste. Foy-lès-Lyon near Lyon, France, the company offers over 1,500 remedies, including mono-preparations, combination formulas, and popular over-the-counter products such as Oscillococcinum for flu relief, Arnicare for pain relief, Stodal for coughs, Arnigel, Camilia for teething, and Verrulia for warts. These are available in forms like tablets, drops, syrups, ointments, and gels, emphasizing low-risk, non-toxic options compliant with regulations including U.S. FDA standards and the Homeopathic Pharmacopoeia. Boiron SA operates in more than 59 countries across Europe, North America, South America, Africa, the Middle East, Asia, and Australia, with subsidiaries and production facilities worldwide. It supports scientific research, trains healthcare professionals, and holds a dominant position in the niche homeopathy market, generating significant revenue primarily from France while expanding internationally through strategic acquisitions like Dolisos in 2005.